Y Intercept Hong Kong Ltd Grows Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Key Points

• Y Intercept Hong Kong Ltd increased its stake in DENTSPLY SIRONA Inc. by 128.3%, acquiring an additional 28,053 shares to bring its total holdings to 49,926 shares worth approximately $746,000.
• DENTSPLY SIRONA reported $0.43 earnings per share for the last quarter, exceeding the consensus estimate of $0.29, despite experiencing a 7.8% decline in revenue year-over-year.
• The company announced a quarterly dividend of $0.16 per share, resulting in an annualized dividend yield of 3.99%, though it has a negative dividend payout ratio of -14.10%.

Y Intercept Hong Kong Ltd boosted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 128.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 49,926 shares of the medical instruments supplier's stock after buying an additional 28,053 shares during the quarter. Y Intercept Hong Kong Ltd's holdings in DENTSPLY SIRONA were worth $746,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in XRAY. Vanguard Group Inc. lifted its holdings in shares of DENTSPLY SIRONA by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock valued at $383,078,000 after purchasing an additional 65,478 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its stake in DENTSPLY SIRONA by 18.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after buying an additional 1,975,404 shares in the last quarter. Fuller & Thaler Asset Management Inc. grew its holdings in DENTSPLY SIRONA by 2.8% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier's stock valued at $219,018,000 after buying an additional 314,343 shares during the last quarter. Lazard Asset Management LLC increased its position in DENTSPLY SIRONA by 23.0% during the fourth quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier's stock worth $152,678,000 after buying an additional 1,505,928 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in DENTSPLY SIRONA by 21.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 6,851,869 shares of the medical instruments supplier's stock worth $130,045,000 after buying an additional 1,230,944 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Piper Sandler decreased their price objective on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 30th. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Barrington Research reissued an "outperform" rating and issued a $21.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, July 22nd. Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Sunday, July 13th. Finally, Morgan Stanley cut shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a research note on Tuesday, April 15th. Ten equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $19.60.

DENTSPLY SIRONA Trading Up 0.2%

Shares of XRAY traded up $0.04 during mid-day trading on Monday, reaching $16.07. The company had a trading volume of 2,779,009 shares, compared to its average volume of 2,843,570. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $27.95. The firm has a fifty day simple moving average of $16.04 and a 200-day simple moving average of $16.17. The stock has a market cap of $3.20 billion, a price-to-earnings ratio of -3.54, a price-to-earnings-growth ratio of 1.14 and a beta of 0.94. The company has a current ratio of 1.10, a quick ratio of 0.76 and a debt-to-equity ratio of 0.79.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million for the quarter, compared to analysts' expectations of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 14.31% and a negative net margin of 24.42%. The firm's revenue for the quarter was down 7.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.42 earnings per share. On average, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were issued a $0.16 dividend. The ex-dividend date of this dividend was Friday, June 27th. This represents a $0.64 annualized dividend and a yield of 3.98%. DENTSPLY SIRONA's payout ratio is -14.10%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.